# WhiteHorse Finance, Inc.: overview

WHF · Nasdaq · CIK 1552198 · [Other](/sectors/other.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/whf.md) · [Financials](/companies/whf/financials.md) · [Filings](/companies/whf/filings.md) · [Insiders](/companies/whf/insiders.md)

Revenue is not reported in this company’s XBRL financial statements.

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | [(0.30)](/filings/0001104659-25-108820.md) | not reported | [0.18](/filings/0001104659-26-056683.md) | [0.10](/filings/0001104659-26-093465.md) | [(0.02)](/filings/0001104659-25-108820.md) | not reported | [(0.03)](/filings/0001104659-26-056683.md) | [0.48](/filings/0001104659-26-093465.md) |
| Free cash flow | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL not reported.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $ | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | [1.42](/filings/0001558370-24-002482.md) | [0.68](/filings/0001410578-25-001398.md) | [0.88](/filings/0001104659-26-024735.md) | [0.47](/filings/0001104659-26-024735.md) | [0.62](/filings/0001104659-26-024735.md) |
| Free cash flow | $ | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL not reported.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/whf/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [Lalia Capital, LLC](/funds/2106818.md) | 2026-06-30 | $4.8m | 712,769 |  | Added +23,664 |
| [TWO SIGMA INVESTMENTS, LP](/funds/1179392.md) | 2026-06-30 | $2.9m | 430,600 |  | Reduced −4,972 |
| [Ethos Financial Group, LLC](/funds/1954242.md) | 2026-06-30 | $2.4m | 360,532 |  | Added +116,592 |
| [CastleKnight Management LP](/funds/1835751.md) | 2026-06-30 | $1.4m | 205,656 |  | Reduced −86,800 |
| [BANK OF AMERICA CORP /DE/](/funds/70858.md) | 2026-06-30 | $1.2m | 185,006 |  | Added +2 |
| [Legal & General Group Plc](/funds/764068.md) | 2026-06-30 | $1.2m | 174,879 |  | Added +5,805 |
| [BANK OF MONTREAL /CAN/](/funds/927971.md) | 2026-06-30 | $769.4k | 114,842 |  | Unchanged |
| [RAYMOND JAMES FINANCIAL INC](/funds/720005.md) | 2026-06-30 | $706.9k | 105,501 |  | Added +83,075 |
| [Blue Trust, Inc.](/funds/1856022.md) | 2026-06-30 | $640.5k | 95,601 |  | Unchanged |
| [Trexquant Investment LP](/funds/1633445.md) | 2026-06-30 | $606.6k | 90,532 |  | Added +23,046 |

## Recent filings

[All 625 filings](/companies/whf/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-14 | 20:39 ET | [8-K/A](/filings/0001104659-26-115860.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-115860 |
| 2026-10-14 | 12:00 ET | [8-K](/filings/0001104659-26-115741.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-115741 |
| 2026-09-15 | 13:11 ET | [8-K](/filings/0001104659-26-107736.md) | 8.01 Other events | 0001104659-26-107736 |
| 2026-08-10 | 21:19 ET | [10-Q](/filings/0001104659-26-093465.md) | Quarterly report, period 2026-06-30 | 0001104659-26-093465 |
| 2026-08-10 | 21:19 ET | [8-K](/filings/0001104659-26-093467.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-093467 |
| 2026-08-04 | 20:50 ET | [8-K](/filings/0001104659-26-090451.md) | 5.07 Shareholder vote results | 0001104659-26-090451 |
| 2026-07-28 | 12:00 ET | [8-K](/filings/0001104659-26-087314.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-087314 |
| 2026-06-18 | 11:30 ET | [DEF 14A](/filings/0001104659-26-075429.md) | Proxy statement, period 2026-08-03 | 0001104659-26-075429 |
| 2026-05-07 | 11:31 ET | [10-Q](/filings/0001104659-26-056683.md) | Quarterly report, period 2026-03-31 | 0001104659-26-056683 |
| 2026-05-07 | 11:31 ET | [8-K](/filings/0001104659-26-056685.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-056685 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001104659-26-024735.md), filed Mar 6, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 1552198
- Tickers: WHF, WHFCL
- Exchange: Nasdaq
- SIC code: not reported
- State of incorporation: DE
- Filer category: Accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:42 ET. No prices; not investment advice.